Bayesian Capital Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-34,021
Closed -$1.43M 287
2025
Q3
$1.43M Buy
34,021
+20,400
+150% +$897K 0.29% 100
2025
Q2
$599K Sell
13,621
-46,847
-77% -$2.12M 0.09% 252
2025
Q1
$3.05M Buy
60,468
+33,700
+126% +$1.67M 0.5% 43
2024
Q4
$1.15M Buy
+26,768
New +$1.13M 0.14% 212
2024
Q2
Sell
-42,146
Closed -$1.39M 877
2024
Q1
$1.39M Buy
+42,146
New +$1.46M 0.13% 212
2023
Q4
Sell
-7,066
Closed -$256K 853
2023
Q3
$256K Buy
+7,066
New +$262K 0.03% 508
2021
Q1
Sell
-5,600
Closed -$232K 591
2020
Q4
$232K Buy
+5,600
New +$221K 0.06% 350
2020
Q1
Sell
-28,969
Closed -$1.22M 841
2019
Q4
$1.22M Sell
28,969
-35,800
-55% -$1.43M 0.21% 145
2019
Q3
$2.51M Buy
64,769
+24,600
+61% +$975K 0.47% 45
2019
Q2
$1.53M Buy
40,169
+5,100
+15% +$185K 0.32% 89
2019
Q1
$1.23M Buy
+35,069
New +$1.11M 0.24% 132
2018
Q1
Sell
-29,361
Closed -$932K 666
2017
Q4
$932K Sell
29,361
-921
-3% -$28.5K 0.19% 181
2017
Q3
$871K Buy
+30,282
New +$862K 0.21% 152
2016
Q2
Sell
-18,200
Closed -$495K 444
2016
Q1
$495K Buy
+18,200
New +$461K 0.47% 40

Other funds holding G

Bayesian Capital Management's G Position: Q4 2025 in Review

Bayesian Capital Management sold out of Genpact (G) in Q4 2025, closing a stake of 34,021 shares — an estimated $1.43M sold.

Bayesian Capital Management first reported a position in G in Q1 2016 and held it in 14 quarters. The position peaked at $3.05M in Q1 2025. 522 funds tracked by Wall St. Rank hold G as of Q4 2025.

  • Bayesian Capital Management reported no remaining Genpact position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 34,021 Genpact shares in Q4 2025, an estimated $1.43M.
  • Bayesian Capital Management first reported a position in Genpact in Q1 2016 and held it in 14 quarters.
  • Bayesian Capital Management's Genpact position peaked at $3.05M in Q1 2025.
  • 522 funds tracked by Wall St. Rank held Genpact as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.